How antirheumatic drugs protect joints from damage in rheumatoid arthritis.
Schett
Georg
G
Department of Internal Medicine III, Institute for Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany. georg.schett@uk-erlangen.de
Stach
Christian
C
Zwerina
Jochen
J
Voll
Reinhard
R
Manger
Bernhard
B
D018501:Antirheumatic Agents / Q000494:pharmacology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology*; D001862:Bone Resorption / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control; D002358:Cartilage, Articular / Q000276:immunology / Q000503:physiopathology*; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D007375:Interleukin-1 / Q000037:antagonists & inhibitors; D007596:Joints / Q000187:drug effects / Q000503:physiopathology; D010012:Osteogenesis / Q000187:drug effects / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D018501:Antirheumatic Agents; D005938:Glucocorticoids; D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha